These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 20420954)

  • 1. Colorectal cancer: national and international perspective on the burden of disease and public health impact.
    Gellad ZF; Provenzale D
    Gastroenterology; 2010 Jun; 138(6):2177-90. PubMed ID: 20420954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies and resources to address colorectal cancer screening rates and disparities in the United States and globally.
    Potter MB
    Annu Rev Public Health; 2013; 34():413-29. PubMed ID: 23297661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projections of demand and capacity for colonoscopy related to increasing rates of colorectal cancer screening in the United States.
    Vijan S; Inadomi J; Hayward RA; Hofer TP; Fendrick AM
    Aliment Pharmacol Ther; 2004 Sep; 20(5):507-15. PubMed ID: 15339322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer in women: an equal opportunity disease.
    Osias GL; Osias KB; Srinivasan R
    J Am Osteopath Assoc; 2001 Dec; 101(12 Suppl Pt 2):S7-12. PubMed ID: 11794751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Communication and colorectal cancer screening among the uninsured: data from the Health Information National Trends Survey (United States).
    Cairns CP; Viswanath K
    Cancer Causes Control; 2006 Nov; 17(9):1115-25. PubMed ID: 17006717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Projected national impact of colorectal cancer screening on clinical and economic outcomes and health services demand.
    Ladabaum U; Song K
    Gastroenterology; 2005 Oct; 129(4):1151-62. PubMed ID: 16230069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing colorectal cancer screening in community health centers: addressing cancer health disparities through a regional cancer collaborative.
    Taplin SH; Haggstrom D; Jacobs T; Determan A; Granger J; Montalvo W; Snyder WM; Lockhart S; Calvo A
    Med Care; 2008 Sep; 46(9 Suppl 1):S74-83. PubMed ID: 18725837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of comorbidity on colorectal cancer screening in the veterans healthcare system.
    Fisher DA; Galanko J; Dudley TK; Shaheen NJ
    Clin Gastroenterol Hepatol; 2007 Aug; 5(8):991-6. PubMed ID: 17627900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of colorectal cancer screening uptake among men and women in the United States.
    Meissner HI; Breen N; Klabunde CN; Vernon SW
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):389-94. PubMed ID: 16492934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer screening: health impact and cost effectiveness.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):80-9. PubMed ID: 16777546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dimensions of the CRC problem.
    Karsa LV; Lignini TA; Patnick J; Lambert R; Sauvaget C
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):381-96. PubMed ID: 20833343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities to improve colorectal cancer screening in Connecticut through Medicare claims data.
    Van Hoof TJ; Ho SY; Curry M; Gacek P; Brooks AH; Meehan TP
    Conn Med; 2011 Feb; 75(2):69-82. PubMed ID: 21476376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case for direct colonoscopy screening for colorectal cancer.
    Bond JH
    Am J Gastroenterol; 2006 Feb; 101(2):263-5. PubMed ID: 16454828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening.
    Heitman SJ; Manns BJ; Hilsden RJ; Fong A; Dean S; Romagnuolo J
    CMAJ; 2005 Oct; 173(8):877-81. PubMed ID: 16217110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surveillance and cost-effectiveness of colonoscopy in asymptomatic increased risk subjects of colorectal cancer: Ferrara experience].
    Matarese V; Pezzoli A; Trevisani L; Boccia S; Brancaleoni M; Simone L; Feo C; Gullini S
    Recenti Prog Med; 2004; 95(7-8):352-7. PubMed ID: 15303544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.